Migraine and coronary artery disease: An open study on the genetic polymorphism of the 5, 10 methylenetetrahydrofolate (MTHFR) and angiotensin I-converting enzyme (ACE) genes

Central Nervous System Agents in Medicinal Chemistry

Volumn 10, Issue 2, 2010, Pages 91-96

  Pizza, V ^a   Bisogno, A ^b   Lamaida, E ^a   Agresta, A ^a   Bandieramonte, G ^a   Volpe, A ^a   Galasso, R ^a   Galasso, L ^a   Caputo, M ^b   Tecce, M F ^b   Capasso, A ^b  

^a S Luca Hospital   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Migraine; Polymorphism; Stroke

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; METHYLENETETRAHYDROFOLIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA;

EID: 77953678042     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152410791196404     Document Type: Article

References (29)

1. Tzourio, C.; Iglesias, S.; Hubert, J.B.; Visy, J.M.; Alpérovitch, A.; Tehindrazanarivelo, A.; Biousse, V.; Woimant, F.; Bousser, M.G. Migraine and risk of ischaemic stroke: a case-control study. BMJ, 1993, 307, 289-292
2. Kurth, T. Migraine and ischaemic vascular events. Cephalalgia, 2008, 27, 965-975.
3. Etminam, M.; Takkouche, B.; Isorna, F.C.; Samii, A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observatinal studies. BMJ, 2005, 330, 63-65
4. Thomas, D.J. Migraine and ischaemic stroke. BMJ, 2005, 330, 54-55.
5. Gretchen, E.; Tietjen, M.D. Migraine and ischaemic heart disease and stroke: potential mechanism and treatment implications, Cephalalgia, 2007, 27, 981-987.
6. Siniscalchi, A.; Callelli, L.; Serafini, O.; Scornaienghi, D.; De Sarro, G. Emicrania e stroke ischemico: meccanismi patofisiologici e trattamento farmacologico. Neurobiologia, 2007, 53, 187-195.
7. Bartolini, M.; Baruffaidi, R.; Paolini, I.; Silvestrini,M. Cerebral blood flow changes in the different phases of migraine. Funct. Neu-rol., 2005, 20, 209-211.
8. Bigal, M.E.; Lipton, R.B. Migraine as a risk factor for deep brain lesions and cardiovascular disease. Cephalalgia, 2007, 27, 976-980.
9. Crassard, I.; Conard, J.; Bousser, M.G. Migraine and haemostasis. Cephalalgia, 2001, 21, 630-636.
10. Chiodini, B.D.; Barlera, S.; Franzosi, M.G.; Rognoni, G. I geni disuscettibilità all'infarto: una revisione della letteratura. Ital. Heart J. Suppl., 2001, 2, 7-14.
11. Venti, M.; Parnetti, L.; Capocchi, G.; Agnelli, G. Genetica dell'ictus ischemico. Neurol. Sci., 2004, 25, S471-S474.
12. Schelleman, H.; Klungel, O.H.; van Duijn, C.M.; Witte-man, J.C.M.; Hofman, A.; de Boer, A.; Stricker, B.H. Drug-gene interaction between the insertion/deletion polymorphism of the an-giotensin-converting enzyme gene and antihypertensive therapy. www.theannals.com, published online, 31 January 2006.
13. Casas, J.P.; Hingorani, A.D.; Bautista, L.E.; Sharma, P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol., 2004, 61, 1652-61.
14. Paterna, S.; Di Pasquale, P.; D'Angelo, A.; Seidita, G.; Tuttolo-mondo, A.; Cardinale, A.; Maniscalchi, T.; Follone, G.; Giubilato, A.; Tarantello, M.; Licata, G. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur. Neurol., 2000, 43, 133-136.
15. Kowa, H.; Fusayasu, E.; Ijiri, I.; Ishizaki, K., Yasui, K,; Nakaso, K.; Kusumi, M.; Takeshima, T.; Nakashima, K. Association of the insertion/deletion polymorphism of the angiotensin i-converting enzyme gene in patients of migraine with aura. Neurosci. Lett., 2005, 374, 129-131.
16. Lin, J.J., Wang, P.J.; Chen, CH.; Yueh, K.C.; Lin, S.Z.; Harn, H.J. Homozygous deletion genotype of angiotensin converting enzyme confers protection against migraine in man. Acta Neurol. Taiwan, 2005, 14, 120-125.
17. Lea, R.A.; Ovcaric, M.; Sundholm, J.; Solyom, L.; MacMillan, J.; Griffiths, LR.; Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility. Brain Res. Mol. Brain Res., 2005, 136, 112-117.
18. Tronvik, E.; Stovner, L.J., Bovim, G.; White, L.R.; Gladwin, A.J.; Owen, K.; Schrader, H. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol., 2008, 8, 4-10.
19. Tietjen, G.E.; Herial, N.A.; Utley, C.; White, L.; Yerga-Woolwine, S.; Joe, B. Association of von Willebrand factor activity with ACE I/D and MTHFR C677T polymorphisms in migraine. Cephalalgia, 2009, 29, 960-968.
20. Pezzini, A.; Grassi, M.; Del Zotto, E.; Giossi, A.; Monastero, R.; Dalla Volta, G.; Archetti, S.; Zavarise, P.; Camarda, C.; Gasparotti, R.; Magoni, M.; Camarda, R.; Padovani, A. L'emicrania media l'influenza dei genotipi di C677T MTHFR sul rischio ischemico del colpo con un effetto di colpo-sottotipo. Stroke, 2008, 3, 24-27.
21. Moschiano, F.; D'Amico, D.; Ciusani, E.; Erba, N.; Rigamonti, A.; Schieroni, F.; Bussone, G. Coagulation abnormalities in migraine and ischaemic cerebrovascular disease: a link between migraine and ischaemic stroke? Neurol. Sci., 2005, 25, S126-8.
22. Kowa, H.; Yasui, K.; Takeshima, T.; Urakami, K.; Sakai, F.; Naka-shima, F. The homozygous C677T mutation in the methylenetetra-hydrofolate reductase gene is a genetic risk factor for migraine. Am. J. Med. Genet., 2000, 96, 762-764.
23. Kara, I.; Sazei, A.; Ergul, E.; Kaya, G.; Kilie, G. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahy-drofolate reductase gene in patients with migraine risk. Brain Res. Mol. Brain Res., 2003, 111, 84-90.
24. Oterino, A.; Valle, N.; Bravo, Y.; Munoz, P.; Sanchez-Velasco, P.; Ruiz-Alegria, C.; Castello, J.; Leyva-Cobian, F.; Vadillo, A.; Pascal, J. MTHFR C677T homozygosis influences the presence of aura in migraineurs. Cephalalgia, 2004, 24, 491-494.
25. Frosst, P.; Blom, H.J.; Milo, R.; Goyette, P.; Sheppard, C.A.; Matthews, R.J.; Boers, G.J.; den Heijer, M.; Kluijtmans, L.A.; van den Heuvel, L.P. A candidate genetic risk factor for vascular disease: a common mutation im methylenetetrahydrofolate reductase. Nat. Genet., 1995, 10, 111-113.
26. van der Put, N.M.; Gabreels, F.; Stevens, E.M.; Smeitink, J.A.; Trijbels, F.J.; Eskes, T.K.; van den Heuvel, L.P.; Bloom, H.J. A second common mutation in the methylenetetrahydrofolate reduc-tase gene: an additional risk factor for neural-tube defects? Am. J. Hum. Genet., 1998, 62, 1044-1051.
27. Bianchi, A.; Salomone, S.; Caraci, F.; Pizza, V.; Bernardini, R.; D'Amato, C.C. Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis. Vitam. Horm., 2004, 69, 297-312.
28. Diamond, S. Diagnosis and treatment of migraine. Headache Quarterly, 1993, 6, 8-14.
29. Schieffer, B. Interaction of interleukin-6 and angiotensin II in atherosclerosis: Culprit for inflammation? Eur. Heart J., 2003, Suppl 5: A25-A30.